Imagen de Portada

Decentralized Clinical Trials in the Era of Real-World Evidence: A Statistical Perspective

Fuente: arXiv

Guardado en:

Detalles Bibliográficos
Autores principales:	Chen, Jie, Di, Junrui, Daizadeh, Nadia, Lu, Ying, Wang, Hongwei, Shen, Yuan-Li, Kirk, Jennifer, Rockhold, Frank W., Pang, Herbert, Zhao, Jing, He, Weili, Potter, Andrew, Lee, Hana
Formato:	Preprint
Publicado:	2024
Materias:	Applications
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Decentralized Clinical Trials in the Era of Real‐World Evidence: A Statistical Perspective
por: Jie Chen, et al.
Publicado: (2025)

Decentralized Clinical Trials in the Era of Real‐World Evidence: A Critical Assessment of Recent Experiences
por: Hongwei Wang, et al.
Publicado: (2025)

Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
por: Chen, Jie, et al.
Publicado: (2024)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
por: Zhu, Di, et al.
Publicado: (2026)

Considerations for the Integration of Randomized Controlled Trials and Real-World Data
por: Qiu, Sky, et al.
Publicado: (2026)

Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective
por: Chen, Jie, et al.
Publicado: (2024)

A Practical Analysis Procedure on Generalizing Comparative Effectiveness in the Randomized Clinical Trial to the Real-world Trialeligible Population
por: Jiang, Kuan, et al.
Publicado: (2024)

Statistical Inference for Heterogeneous Treatment Effect with Right-censored Data from Synthesizing Randomized Clinical Trials and Real-world Data
por: Mao, Guangcai, et al.
Publicado: (2025)

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties
por: Cui, Ying, et al.
Publicado: (2025)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
por: Yang, Peng, et al.
Publicado: (2026)

An Estimator-Robust Design for Augmenting Randomized Controlled Trial with External Real-World Data
por: Qiu, Sky, et al.
Publicado: (2025)

Regulatory Expectations for Bayesian Methods in Drug and Biologic Clinical Trials: A Practical Perspective on FDA's 2026 Draft Guidance
por: Ji, Yuan, et al.
Publicado: (2026)

Statistical Reinforcement Learning in the Real World: A Survey of Challenges and Future Directions
por: Gazi, Asim H., et al.
Publicado: (2026)

Eligibility-Aware Evidence Synthesis: An Agentic Framework for Clinical Trial Meta-Analysis
por: Zhao, Yao, et al.
Publicado: (2026)

Statistical Design and Rationale of the Biomarkers for Evaluating Spine Treatments (BEST) Trial
por: Sperger, John, et al.
Publicado: (2025)

Combining Unsupervised Learning and Statistical Inference For Multimodal N-of-1 Trials
por: Schneider, Juliana, et al.
Publicado: (2023)

Statistical Design of Pragmatic Trials Using Electronic Health Record Data when Outcome Assessments are Uncontrolled and Irregular
por: Bobb, Jennifer F., et al.
Publicado: (2026)

Applied Statistics in the Era of Artificial Intelligence: A Review and Vision
por: Min, Jie, et al.
Publicado: (2024)

Statistical Consequences of Fat Tails: Real World Preasymptotics, Epistemology, and Applications
por: Taleb, Nassim Nicholas
Publicado: (2020)

Multiple Imputation for Small, Extremely High Efficacy Clinical Trials with Binary Endpoints
por: Tan, Yaoyuan Vincent, et al.
Publicado: (2025)

[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
por: Phillips, Rachael V., et al.
Publicado: (2024)

Application of Markov Chains to Multiple Sclerosis Clinical Trial Data to Estimate Disease Trajectories
por: Sthanu, Uma, et al.
Publicado: (2024)

Considerations for Single-Arm Trials to Support Accelerated Approval of Oncology Drugs
por: Lu, Feinan, et al.
Publicado: (2024)

Heterogeneous Clinical Trial Outcomes via Multi-Output Gaussian Processes
por: Thomas, Owen, et al.
Publicado: (2024)

E-values for Adaptive Clinical Trials: Anytime-Valid Monitoring in Practice
por: Sokolova, Alexandra, et al.
Publicado: (2026)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
por: Maity, Arnab Kumar, et al.
Publicado: (2024)

Predictive Probabilities Made Simple: A Fast and Accurate Method for Clinical Trial Decision Making
por: Marion, Joe, et al.
Publicado: (2024)

Consistency Assessment of Regional Treatment Effect for Multi-Regional Clinical Trials in the Presence of Covariate Shift
por: Qing, Kunhai, et al.
Publicado: (2026)

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
por: Sechidis, Konstantinos, et al.
Publicado: (2024)

Are Large Language Models able to Predict Highly Cited Papers? Evidence from Statistical Publications
por: Ye, Zhanshuo, et al.
Publicado: (2026)

Analyses and Concerns in Precision Medicine: A Statistical Perspective
por: Chen, Xiaofei
Publicado: (2024)

Distribution-Based Sub-Population Selection (DSPS): A Method for in-Silico Reproduction of Clinical Trials Outcomes
por: Ganji, Mohammadreza, et al.
Publicado: (2024)

Extending Inferences from Randomized Clinical Trials to Target Populations: A Scoping Review of Transportability Methods
por: Wang, Guanbo, et al.
Publicado: (2024)

Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
por: Lotspeich, Sarah C., et al.
Publicado: (2026)

Do Bayesian Neural Networks Improve Weapon System Predictive Maintenance?
por: Potter, Michael, et al.
Publicado: (2023)

A Detailed Historical and Statistical Analysis of the Influence of Hardware Artifacts on SPEC Integer Benchmark Performance
por: Wang, Yueyao, et al.
Publicado: (2024)

Forecasting Net Migration By Age: The Flow-Difference Approach
por: Ševčíková, Hana, et al.
Publicado: (2024)

Trustworthy AI/ML Regression and Unbiased Causal Inference for Real-World Data
por: Xu, Yifei, et al.
Publicado: (2026)

A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
por: Zhang, Cong, et al.
Publicado: (2026)

Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
por: Wang, Sidi, et al.
Publicado: (2026)